Delivery Order SPE2DB22D3301-SPE2DB24FZ2FH
Award Date
8/6/24
Potential Completion Date
8/27/24
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $8,118.08 firm fixed-price contract is for the supply of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The contract has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to provide a wide range of...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of IBRANCE 125 MG CAPSULE 21S medication. The $8,118.08 firm fixed-price contract has a completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,123.96, is for the delivery of 4,568,143,236 units of the prescription medication IBRANCE 75 MG CAPSULE 21S. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. The contract has an ultimate completion date of May 27, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,123.96, is for the delivery of 4567925378 IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,393.52, is for the delivery of IBRANCE 75 MG CAPSULE 21S, a specialty medication, to support federal healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,067.35, is for the delivery of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract has a period of performance through March 21, 2025 and is a firm fixed-price contract. The contract is not set aside for any specific socioeconomic program. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has a firm fixed price of $8,122.48 and a completion date of July 25, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,065.75 firm fixed-price delivery order is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through February 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ibrance 125 mg capsules. The $8,118.08 fixed-price contract has a performance period through May 2025 and is not a set-aside. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,796.30 contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a specialty cancer medication. The award has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of...